What is AI Optics?
AI Optics is at the forefront of revolutionizing healthcare diagnostics through its proprietary imaging technology and artificial intelligence. The company's core innovation lies in its ability to screen for diseases using AI-based software, with its FDA-cleared Sentinel Camera already capturing digital eye images. The forthcoming Sentinel Pro is poised to enhance the diagnosis of critical retinal conditions like Diabetic Retinopathy and Glaucoma. AI Optics is strategically targeting a broad market, including primary care physicians, optometrists, health systems, and private medical practices, aiming to deliver diagnostic tools that are not only user-friendly and easily integrated but also economically viable, thereby broadening patient access to essential healthcare services.
How much funding has AI Optics raised?
AI Optics has raised a total of $14.7M across 1 funding round:
Private Equity
$14.7M
Private Equity (2025): $14.7M, investors not publicly disclosed
What's next for AI Optics?
With the recent major strategic investment, AI Optics is well-positioned for accelerated growth and market penetration. The company's focus on developing cost-effective and accessible diagnostic solutions, particularly for prevalent conditions like Diabetic Retinopathy and Glaucoma, aligns with a growing demand for efficient healthcare technologies. This backing is expected to fuel further research and development, potentially expanding the capabilities of the Sentinel platform and solidifying AI Optics' role as a key player in the digital health and medical imaging sector. The company's trajectory suggests a strong emphasis on scaling its operations and broadening its client base within the healthcare ecosystem.
See full AI Optics company page
